Ongoing or recurrent infectious disorders including clinically apparent bacterial or viral infections exclude the application of rituximab. Patients with a history of malignancies or immunodeficiency syndromes, as well as pregnant or lactating women, should not undergo rituximab therapy. Patients with cardiac disorders should be closely monitored during therapy with rituximab. A history of anaphylactic hypersensitivity reactions against mouse proteins also excludes treatment with rituximab.
Was this article helpful?
Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.